We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+5.34%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$400M
AUM Growth
+$156M
(+64%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
41.53%
Top 10 Holdings %
Top 10 Hldgs %
29.1%
Holding
490
New
266
Increased
41
Reduced
24
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$28.6M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.7M |
| 3 |
Pfizer
PFE
|
+$11M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$10.2M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$9.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Paper
IP
|
+$11.1M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$11.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.23M |
| 4 |
UMB Financial
UMBF
|
+$6.83M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$6.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.24% |
| 2 | Financials | 15.91% |
| 3 | Technology | 11.39% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Flotek Industries
FTK
$935M
| $120K | 0.03% |
+14,383
| New | +$124K |
|
302
eHealth
EHTH
$42.5M
| $120K | 0.03% |
+17,910
| New | +$163K |
|
303
Corvus Pharmaceuticals
CRVS
$1.1B
| $116K | 0.03% |
+36,421
| New | +$172K |
|
|
EARN
304
Ellington Residential Mortgage REIT
EARN
$165M
| $115K | 0.03% |
+21,208
| New | +$135K |
|
305
Motorcar Parts of America
MPAA
$261M
| $107K | 0.03% |
+11,298
| New | +$98.6K |
|
306
United States Antimony
UAMY
$766M
| $106K | 0.03% |
+48,328
| New | +$83.8K |
|
307
Rezolute
RZLT
$480M
| $100K | 0.03% |
+34,533
| New | +$150K |
|
308
Personalis
PSNL
$1.26B
| $100K | 0.03% |
+28,495
| New | +$135K |
|
|
MPT
309
Medical Properties Trust
MPT
$2.89B
| $97.3K | 0.02% |
+16,138
| New | +$81.6K |
|
310
Lionsgate Studios
LION
$3.88B
| $93.5K | 0.02% |
+12,517
| New | +$97.8K |
|
311
BGC Group
BGC
$5.58B
| $91.7K | 0.02% |
10,000
-7,075
| -41% | -$66.3K |
|
312
Microvast
MVST
$267M
| $90.5K | 0.02% |
+77,362
| New | +$134K |
|
313
Myomo
MYO
$37.5M
| $87.8K | 0.02% |
+18,255
| New | +$104K |
|
314
Ironwood Pharmaceuticals
IRWD
$611M
| $85.5K | 0.02% |
+58,149
| New | +$138K |
|
315
Aclaris Therapeutics
ACRS
$730M
| $79K | 0.02% |
+51,664
| New | +$110K |
|
316
Vuzix
VUZI
$190M
| $76.5K | 0.02% |
+37,523
| New | +$123K |
|
317
Kopin
KOPN
$663M
| $76.3K | 0.02% |
+81,804
| New | +$120K |
|
|
TSE
318
DELISTED
Trinseo
TSE
| $74.1K | 0.02% |
+20,124
| New | +$91.6K |
|
319
RPC Inc
RES
$1.24B
| $71.5K | 0.02% |
+13,008
| New | +$77.4K |
|
320
Blue Ridge Bankshares
BRBS
$311M
| $68.9K | 0.02% |
+21,129
| New | +$72.2K |
|
321
Eledon Pharmaceuticals
ELDN
$276M
| $56K | 0.01% |
+16,523
| New | +$68K |
|
|
RPT
322
Rithm Property Trust
RPT
$90.5M
| $54.6K | 0.01% |
+3,172
| New | +$57.4K |
|
323
Douglas Elliman
DOUG
$155M
| $50.4K | 0.01% |
+29,292
| New | +$53K |
|
324
Atomera
ATOM
$201M
| $50.1K | 0.01% |
+12,515
| New | +$97.4K |
|
325
Citizens
CIA
$245M
| $47.7K | 0.01% |
+10,480
| New | +$50.5K |
|
Similar funds
FS
BC
HAM
DP
SPC
IW
SRHG
MPW
Quantessence Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Quantessence Capital held 490 positions worth $400M, up 64% from $244M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Quantessence Capital deployed $166M of net new capital in Q1 2025, opening 266 new positions and adding to 41 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $11.1M trimmed.
- Quantessence Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
- Quantessence Capital added most to Beacon Roofing Supply, Inc. in Q1 2025, an estimated $9.88M increase.
- Quantessence Capital's biggest Q1 2025 reduction was iShares US Real Estate ETF, cutting an estimated $11.1M.
- Quantessence Capital fully exited International Paper in Q1 2025, selling an estimated $11.1M.
- Quantessence Capital's ten largest holdings make up 29% of its $400M portfolio in Q1 2025.
- Quantessence Capital opened 266 new positions and closed 158 in Q1 2025.
- Quantessence Capital's portfolio value rose 64% quarter-over-quarter to $400M.
Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.